ZIVO (Zivo Bioscience) Total Operating Expense: $8.52 Mil (TTM As of Sep. 2025)


ZIVO Zivo Bioscience Inc ZIVO
8 GF Score
Price $5.25
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience Total Operating Expense?

Zivo Bioscience ZIVO 8 Total Operating Expense is $8.52 Mil as of Sep. 2025. GuruFocus rates ZIVO with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

Zivo Bioscience's Total Operating Expense for the three months ended in Sep. 2025 was $1.04 Mil. Zivo Bioscience's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 was $8.52 Mil.

Zivo Bioscience Total Operating Expense Related Terms

Zivo Bioscience Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Zivo Bioscience's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zivo Bioscience Total Operating Expense Chart

Zivo Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.58 8.65 8.73 7.28 13.41

Zivo Bioscience Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.27 1.62 4.21 1.65 1.04
ZIVO
8GF Score
Zivo Bioscience Inc ZIVO
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zivo Bioscience Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $8.52 Mil mean?
Zivo Bioscience (ZIVO) has a Total Operating Expense of $8.52 Mil as of Sep. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Zivo Bioscience and its competitors.
Is Zivo Bioscience's Total Operating Expense too high?
Zivo Bioscience's current Total Operating Expense is $8.52 Mil. Overall, Zivo Bioscience has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Total Operating Expense compare to ATOS and QNCX?
Zivo Bioscience's Total Operating Expense of $8.52 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Zivo Bioscience and its competitors. Zivo Bioscience's current Total Operating Expense is $8.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Total Operating Expense of $8.52 Mil. The current Total Operating Expense is $8.52 Mil. Zivo Bioscience's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Total Operating Expense is $8.52 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
8GF Score

Get the complete analysis for ZIVO

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price